Atropos Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Early Stage VC
- Investors
-
4
Atropos Therapeutics General Information
Description
Developer of anti-aging drugs designed to treat age-related diseases and cancer. The company's drugs are discovered to improve healthspan with approved novel senescence targeting drugs and it identifies chemical matter that can modulate the formation of senescent cells both for aging application and oncology application, enabling patients to avail anti-aging medicines.
Contact Information
Website
www.atroposthera.comCorporate Office
- PO Box 412
- Belmont, CA 94002
- United States
Corporate Office
- PO Box 412
- Belmont, CA 94002
- United States
Atropos Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC | 01-Oct-2022 | Completed | Startup | |||
| 4. Seed Round | 16-Jul-2021 | Cancelled | Startup | |||
| 3. Grant | 30-Sep-2018 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
Atropos Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Atropos Therapeutics Patents
Atropos Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230226089-A1 | Methods and compositions for treating diseases associated with senescence | Inactive | 04-Jan-2019 |
Atropos Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Atropos Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Incite Ventures (San Francisco) | Venture Capital | Minority | ||
| U.S. Department of Health and Human Services | Government | |||
| California Life Sciences | Accelerator/Incubator | |||
| MBC BioLabs | Accelerator/Incubator |
Atropos Therapeutics Investments (1)
Atropos Therapeutics’s most recent deal was a Joint Venture with Atomwise & Atropos (Joint Venture). The deal was made on 11-Sep-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Atomwise & Atropos (Joint Venture) | 11-Sep-2019 | Joint Venture | Drug Discovery |
Atropos Therapeutics FAQs
-
When was Atropos Therapeutics founded?
Atropos Therapeutics was founded in 2018.
-
Where is Atropos Therapeutics headquartered?
Atropos Therapeutics is headquartered in Belmont, CA.
-
What is the size of Atropos Therapeutics?
Atropos Therapeutics has 3 total employees.
-
What industry is Atropos Therapeutics in?
Atropos Therapeutics’s primary industry is Drug Discovery.
-
Is Atropos Therapeutics a private or public company?
Atropos Therapeutics is a Private company.
-
What is Atropos Therapeutics’s current revenue?
The current revenue for Atropos Therapeutics is .
-
Who are Atropos Therapeutics’s investors?
Incite Ventures (San Francisco), U.S. Department of Health and Human Services, California Life Sciences, and MBC BioLabs have invested in Atropos Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
